Yashwanth Ashok - Publications

Affiliations: 
Genome Sciences University of Washington, Seattle, Seattle, WA 
Area:
Protein methods ; Biochemistry

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Vela-Rodríguez C, Scarpulla I, Ashok Y, Lehtiö L. Discovery of DTX3L inhibitors through a homogeneous FRET-based assay that monitors formation and removal of poly-ubiquitin chains. Slas Discovery : Advancing Life Sciences R & D. PMID 37579950 DOI: 10.1016/j.slasd.2023.08.005  0.634
2023 Murthy S, Nizi MG, Maksimainen MM, Massari S, Alaviuhkola J, Lippok BE, Vagaggini C, Sowa ST, Galera-Prat A, Ashok Y, Venkannagari H, Prunskaite-Hyyryläinen R, Dreassi E, Lüscher B, Korn P, et al. [1,2,4]Triazolo[3,4-]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes. Journal of Medicinal Chemistry. PMID 36598465 DOI: 10.1021/acs.jmedchem.2c01460  0.695
2022 Ashok Y, Vela-Rodríguez C, Yang CS, Alanen HI, Liu F, Paschal BM, Lehtiö L. Reconstitution of the DTX3L-PARP9 complex reveals determinants for high affinity heterodimerization and multimeric assembly. The Biochemical Journal. PMID 35037691 DOI: 10.1042/BCJ20210722  0.622
2020 Ashok Y, Maksimainen MM, Kallio T, Kilpeläinen P, Lehtiö L. FMN-dependent oligomerization of putative lactate oxidase from Pediococcus acidilactici. Plos One. 15: e0223870. PMID 32092083 DOI: 10.2210/Pdb6Rht/Pdb  0.618
2020 Ashok Y, Miettinen M, Kimio Hirabae de Oliveira D, Tamirat M, Näreoja K, Tiwari A, Hottiger MO, Johnson M, Lehtiö L, Pulliainen AT. Discovery of compounds inhibiting the ADP-ribosyltransferase activity of pertussis toxin. Acs Infectious Diseases. PMID 31899865 DOI: 10.1021/Acsinfecdis.9B00412  0.685
2018 Murthy S, Desantis J, Verheugd P, Maksimainen MM, Venkannagari H, Massari S, Ashok Y, Obaji E, Nkizinkinko Y, Lüscher B, Tabarrini O, Lehtiö L. 4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10. European Journal of Medicinal Chemistry. 156: 93-102. PMID 30006177 DOI: 10.1016/J.Ejmech.2018.06.047  0.689
2016 Venkannagari H, Verheugd P, Koivunen J, Haikarainen T, Obaji E, Ashok Y, Narwal M, Pihlajaniemi T, Lüscher B, Lehtiö L. Small-Molecule Chemical Probe Rescues Cells from Mono-ADP-Ribosyltransferase ARTD10/PARP10-Induced Apoptosis and Sensitizes Cancer Cells to DNA Damage. Cell Chemical Biology. PMID 27667561 DOI: 10.1016/J.Chembiol.2016.08.012  0.668
2016 Ashok Y, Jaakola VP. Nanodisc-Tm: Rapid functional assessment of nanodisc reconstituted membrane proteins by CPM assay. Methodsx. 3: 212-8. PMID 27054097 DOI: 10.1016/J.Mex.2016.03.009  0.651
2015 Rehan S, Ashok Y, Nanekar R, Jaakola VP. Thermodynamics and kinetics of inhibitor binding to human equilibrative nucleoside transporter subtype-1. Biochemical Pharmacology. PMID 26428002 DOI: 10.1016/J.Bcp.2015.09.019  0.669
2015 Ashok Y, Nanekar R, Jaakola VP. Defining thermostability of membrane proteins by western blotting. Protein Engineering, Design & Selection : Peds. 28: 539-42. PMID 26384510 DOI: 10.1093/Protein/Gzv049  0.656
2013 Ashok Y, Nanekar RT, Jaakola VP. Crystallogenesis of adenosine A(2A) receptor-T4 lysozyme fusion protein: a practical route for the structure. Methods in Enzymology. 520: 175-98. PMID 23332700 DOI: 10.1016/B978-0-12-391861-1.00008-3  0.67
2011 Piirainen H, Ashok Y, Nanekar RT, Jaakola VP. Structural features of adenosine receptors: from crystal to function. Biochimica Et Biophysica Acta. 1808: 1233-44. PMID 20595055 DOI: 10.1016/J.Bbamem.2010.05.021  0.663
2009 Ashok Y. Drosophila toll pathway: the new model. Science Signaling. 2: jc1. PMID 19126860 DOI: 10.1126/Scisignal.252Jc1  0.323
Show low-probability matches.